Rigcef-SB 750 Injection

Powerful Antibiotic Combination for Bacterial Infections

Rigcef-SB 750 Injection contains Ceftriaxone 500 mg and Sulbactam 250 mg, a clinically trusted antibiotic combination used for the treatment of a wide range of bacterial infections. The formulation combines the broad-spectrum antibacterial action of Ceftriaxone with the beta-lactamase inhibitory effect of Sulbactam, helping improve efficacy against resistant bacteria.

Composition

Each vial contains:

• Ceftriaxone 500 mg
• Sulbactam 250 mg

Mechanism of Action (MOA)

Ceftriaxone

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis. By disrupting the formation of the bacterial cell wall, it causes bacterial death and helps eliminate infection.

Sulbactam

Sulbactam is a beta-lactamase inhibitor that protects Ceftriaxone from degradation by beta-lactamase enzymes produced by certain resistant bacteria. This enhances the effectiveness of Ceftriaxone and broadens its antibacterial spectrum.

Key Benefits

• Broad-spectrum antibacterial coverage
• Effective against susceptible Gram-positive and Gram-negative bacteria
• Helps combat beta-lactamase-producing organisms
• Supports faster infection control and recovery
• Widely used in hospitals and healthcare settings
• Trusted combination for moderate to severe bacterial infections

Indications

Rigcef-SB 750 Injection may be prescribed for the treatment of:

• Respiratory tract infections
• Pneumonia
• Acute bronchitis
• Urinary tract infections (UTIs)
• Skin and soft tissue infections
• Intra-abdominal infections
• Bone and joint infections
• Ear, nose and throat infections
• Gynecological infections
• Septicemia (bloodstream infections)
• Post-operative infections
• Typhoid fever and other susceptible bacterial infections

Why Choose Rigcef-SB 750?

Rigcef-SB 750 combines the proven efficacy of Ceftriaxone with the resistance-fighting support of Sulbactam. This dual-action approach helps healthcare professionals manage bacterial infections more effectively, especially in cases where bacterial resistance may be a concern.

Dosage and Administration

The dosage and duration of therapy should be determined by a qualified healthcare professional based on the type and severity of infection, patient age, and clinical condition.

Safety Information

• To be administered only under medical supervision.
• Not indicated for viral infections such as the common cold or flu.
• Inform your healthcare provider about any history of allergy to cephalosporins, penicillins, or other antibiotics.
• Store in a cool and dry place as per label instructions.
• Keep out of reach of children.